Clinical Trials at St. Josef-Hospital, Klinik für Neurologie
During the past decade, St. Josef-Hospital, Klinik für Neurologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Josef-Hospital, Klinik für Neurologie"
#1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "Ruhr University of Bochum" with 1 trials as a collaborator, "University Hospital Muenster" with 1 trials as a collaborator and "University of Ulm" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at St. Josef-Hospital, Klinik für Neurologie
According to Clinical.Site data, the most researched conditions in "St. Josef-Hospital, Klinik für Neurologie" are
"Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer Disease" (1 trials), "Apathy" (1 trials), "Generalized Myasthenia Gravis" (1 trials) and "Huntington Disease" (1 trials). Many other conditions were trialed in "St. Josef-Hospital, Klinik für Neurologie" in a lesser frequency.
Clinical Trials Intervention Types at St. Josef-Hospital, Klinik für Neurologie
Most popular intervention types in "St. Josef-Hospital, Klinik für Neurologie" are "Drug" (9 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ocrelizumab" (3 trials), "Satralizumab" (3 trials), "(2)-epigallocatechin-3-gallate (EGCG)" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Josef-Hospital, Klinik für Neurologie
The vast majority of trials in "St. Josef-Hospital, Klinik für Neurologie" are
10 trials for "All" genders.
Clinical Trials Status at St. Josef-Hospital, Klinik für Neurologie
Currently, there are NaN active trials in "St. Josef-Hospital, Klinik für Neurologie".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in St. Josef-Hospital, Klinik für Neurologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St. Josef-Hospital, Klinik für Neurologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".